A Prospective, Randomized Controlled Trial Comparing Traditional Methods of Neuromuscular Block Reversal to Sugammadex for Extubation in the Operating Room in ASA 4 and 4E Patients

NCT01761552 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Neuromuscular Blockade

Interventions

DRUG: Sugammadex Reversal
DRUG: Atropine/Neostigmine

Sponsor

Hadassah Medical Organization